Deutsche Biotech Innovativ AG

DUSE:DBI 株式レポート

時価総額：€1.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Deutsche Biotech Innovativ マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Bernd Wegener

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権n/a
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

What Kind Of Investors Own Most Of Deutsche Biotech Innovativ AG (DUSE:DBI)?

Feb 17
What Kind Of Investors Own Most Of Deutsche Biotech Innovativ AG (DUSE:DBI)?

Deutsche Biotech Innovativ (DUSE:DBI) Is In A Good Position To Deliver On Growth Plans

Dec 02
Deutsche Biotech Innovativ (DUSE:DBI) Is In A Good Position To Deliver On Growth Plans

CEO（最高経営責任者

Bernd Wegener (77 yo)

no data

在職期間

Dr. Bernd Wegener, FRICS, serves as the Chairman of Management Board and Chief Executive Officer at Deutsche Biotech Innovativ AG. Dr. Wegener served as Chairman of the Supervisory Board of Adrenomed AG un...